Theriva Biologics, Inc. (TOVX) vs VistaGen Therapeutics, Inc. (VTGN)
- Theriva Biologics, Inc. TOVX 0.21 0.00%
- VistaGen Therapeutics, Inc. VTGN 0.20 −4.76%
Theriva Biologics, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Theriva Biologics, Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.7M and $9.5M). VistaGen Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.1×. Theriva Biologics, Inc. has the higher net margin (0.00% vs −2,703.7%) and the lower return on invested capital (−301.7% vs 0.00%). Across the 15 metrics below, Theriva Biologics, Inc. leads on 10 and VistaGen Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | TOVX | VTGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (2,785.69%) | 0.00% |
| Net margin | 0.00% | (2,703.72%) | 0.00% |
| Free cash flow margin | 0.00% | (2,490.88%) | 0.00% |
| Return on equity | (115.11%) | (166.46%) | (56.36%) |
| Return on assets | (37.14%) | (129.22%) | (48.04%) |
| Return on invested capital | (301.72%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack